MAPT and Alzheimer disease: We confirmed this result through our follow-up immunohistochemistry studies and propose that the AD risk factor APOEε4 facilitates Tau-pathology progression by enhancing the accumulation of pTau in axonal endings and synapses, particularly in Aβ-affected brain regions.